chrisvoncsefalvay/vaers-outcomes huggingface dataset:
starting to lose range of motion; I still have soreness in my arm; This spontaneous case was reported by a patient and describes the occurrence of MOBILITY DECREASED (starting to lose range of motion) and MYALGIA (I still have soreness in my arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (starting to lose range of motion) and MYALGIA (I still have soreness in my arm). At the time of the report, MOBILITY DECREASED (starting to lose range of motion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant information were not reported. Treatment information were not reported.
Brought back urticaria within 10 days of the shot. I am now taking 7 antihistamines a day, as well as, Plaquenil 200mg to control my hives.
Pt. passed out, hit floor 5 minutes after vaccine.  Vs 130/78, HR 68, OxSat. 98%.  Pt on floor, legs elevated, water offered. Pt is now able to sit down in chair un-assisted.
Swelling and tenderness at right deltoid at and around injection site. Notice 1 day after vaccination. No rash, no SOB, no other complaints. Rx- cold compress and motrin 2 tsp PO q6 hr PRN and gentle massage.
Nurse administered Moderna bivalent booster to patient, after confirming from the (record) that her last vaccination was 05/06/2022. She was monitored, no adverese reaction or distress noted.  Minutes after vaccination, pt.'s  daughter called the clinic stated that patient already received her Bivalent booster 2 weeks ago.
This spontaneous report was received from a other health professional (nurse) refers to a patient of unknown age and gender. On 02-JAN-2015 the patient was vaccinated with improperly stored VAQTA (lot  K008252, expiration date: 24-OCT-2015), .5 ml, doses (unspecified in series) intramuscular. No adverse effects were reported. Outcome of the event was not reported. Reporter considered the event to be not related to VAQTA. This is one of several reports received from the same source (MARRS # 1501USA003826, MARRS # 1501USA004956, MARRS # 1501USA004958, MARRS # 1501USA004959 and 1501USA004960. Additional information has been requested.
This spontaneous report was received from a 51 year old (reported as 51) female patient, who was reporting on herself. Her medical history and concurrent conditions were not reported. On 14-SEP-2016, the patient was vaccinated with PNEUMOVAX 23 lot # reported as L034335 with expiration date of 18-MAY-2017 (dose, frequency and route of administration were not reported). No concomitant medications were reported. On 15-SEP-2016 (reported as 24 hours later), the patient experienced redness, hot to touch, did not feel well and from shoulder to elbow it was hard in a spot and painful. Therefore, the patient received an unspecified treatment. No product quality complaints were involved. At the time of reporting, the outcome of the events was reported as recovering. Additionally, the relatedness between the events and the suspect therapy was not provided by the reporter. Additional information is not expected as no reporter contact details were provided.
Patient had vasovagal syncope and passed out immediately after receiving the vaccination. She immediately came too and presented no further symptoms from the incident. Upon follow up with the patient the next morning, she was not having any symptoms and felt normal.
tinnitis, weak fatigue, brain fog, eyes blur, NV and diarrhea at the start, arm sore and rash over a week
Severe and continue headaches for months, followed by two heart attacks on Sept 7, resulting in damaged heart artery leading to death on September 17, 2021 at 3AM.
Severe pain in hand; Severe pain in the upper right arm; Severe pain in the shoulder joints; Late second dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Severe pain in hand), VACCINATION SITE PAIN (Severe pain in the upper right arm), ARTHRALGIA (Severe pain in the shoulder joints) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Late second dose) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Pacemaker insertion (cardiac). Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Late second dose). On an unknown date, the patient experienced PAIN IN EXTREMITY (Severe pain in hand), VACCINATION SITE PAIN (Severe pain in the upper right arm) and ARTHRALGIA (Severe pain in the shoulder joints). On 08-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Late second dose) had resolved. At the time of the report, PAIN IN EXTREMITY (Severe pain in hand), VACCINATION SITE PAIN (Severe pain in the upper right arm) and ARTHRALGIA (Severe pain in the shoulder joints) outcome was unknown.            Concomitant medications also included varsakin, infesil and hidrocloroside.  It was also reported that patient did not took any medication to alleviate the symptoms.
Sore arm; Redness around injection site; Tender breasts; Sore breasts; Sore, tender to touch in the armpit of right arm (Sidewhere injection took place); Swollen lymph node in the armpit area.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 04Mar2021 at 15:15 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included indoor or outdoor allergies, knee arthritis, back disorder, migraine and sinus disorder. The patient was not aware of any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications included cyanocobalamin (VITAMIN B12), iron (MANUFACTURER UNKNOWN), OTC allergy meds (MANUFACTURER UNKNOWN) and multivitamins (MANUFACTURER UNKNOWN) for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 11Mar2021, the patient experienced sore arm from time of shot to about 24 hours next day. redness around injection site for about 2 days, sore or tender breasts about 4 days.  About a week later, it was sore, tender to touch in the armpit of right arm (side where injection took place). That also came with swollen lymph node in the armpit area, began about a week from day of 1st shot and is still a bit tender the day of reporting. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events sore arm, redness around injection site, sore or tender breasts, sore, tender to touch in the armpit of right arm and swollen lymph node in the armpit area was recovering at the time of report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
A few minutes after vaccine administration patient bacame lightheadded, dizzy, and nauseated.  Patient has experienced this before with other vaccines.
Left lip, cheek and nare swollen very visible  to others.  No difficulty breathing or swallowing .  She has been taking zertec and this has resolved some but not all of the swelling.
p/vax pt exp chickenpox w/more than 50 lesions located on entire body, including the area around eyes;also exp a fever & cough;pt sought unspecified medical attention & was treated w/DPh;
hot flushes; light-headedness/feeling kind of lightheaded; Caller is not feeling that good; Caller only received two total doses of Pfizer Vaccine and the Pfizer Booster was the caller's second dose received; sweating; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 79-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 15May2023 as dose 2, single (Batch/Lot number: unknown) at the age of 79 years, in right arm for covid-19 immunisation. The patient didn't receive BNT162b2 (BNT162B2). The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (First dose: 10Jun2022, lot/NDC/expiration: Unknown, doesn't have that written on the vaccine card. Route of administration: right side of arm), administration date: 10Jun2022, when the patient was 78-year-old, for COVID-19 immunization. The following information was reported: WRONG PRODUCT ADMINISTERED (non-serious) with onset 15May2023, outcome "unknown", described as "Caller only received two total doses of Pfizer Vaccine and the Pfizer Booster was the caller's second dose received"; HYPERHIDROSIS (non-serious) with onset May2023, outcome "not recovered", described as "sweating"; MALAISE (non-serious) with onset 16May2023, outcome "unknown", described as "Caller is not feeling that good"; HOT FLUSH (non-serious) with onset 16May2023, outcome "not recovered", described as "hot flushes"; DIZZINESS (non-serious) with onset 16May2023, outcome "recovering", described as "light-headedness/feeling kind of lightheaded". Additional information: Sweating a lot began two or three days after "Mother's Day". Feeling kind of lightheaded began second day after receiving the Pfizer Booster. Doesn't have light headedness that much. Does still have hot flushes. Patient only received two total doses of Pfizer Vaccine and the Pfizer Booster was the patient's second dose received.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.
This case was reported by a consumer via call center representative and described the occurrence of jaw pain in a female patient who received MEN B NVS. On an unknown date, the patient received Meningococcal B vaccine. On 7th AUGUST 2016, 7 days after receiving Meningococcal B vaccine, the patient experienced injection site rash. On an unknown date, the patient experienced jaw pain, rash and headache. In August 2016, the outcome of the headache was recovered/resolved. On an unknown date, the outcome of the jaw pain and injection site rash were not recovered/not resolved and the outcome of the rash was unknown. It was unknown if the reporter considered the jaw pain, rash, headache and injection site rash to be related to Meningococcal B vaccine. Additional details were provided as follows: The age at vaccination was not reported. This case was reported by the patient's mother. The patient was administered with a Meningitis B Vaccination at 10 AM about a week ago. By noon, the patient experienced hurting in her jaw. At the time of reporting there was a lot of pain in her jaw. Later, the patient experienced a rash which seemed to move around, headache for about three days and rash that appeared on lower face, neck and chest. The patient did not complain about the headache after it had been recovered. At the time of reporting, 7 days after vaccination, the patient experienced rash was on the patient's arm where she received the vaccine. The reporter was inquiring about, was it related to vaccination and if they should be concerned about it and what should be done.
The patient is a 37-year-old male who was brought to the emergency room by ambulance.  He tested positive for COVID as an outpatient on January 10.  He began to have some symptoms of shortness of breath beginning January 8.  He received a prescription for Medrol Dosepak and was taking vitamin C and zinc.  However, after completing the Medrol Dosepak, he again began having symptoms, which now included fatigue, noted to be quite severe and limiting his activity.  On the admission day, he was brought to the ER by ambulance, and he developed central chest tightness with shortness of breath.  EMS found him extremely distressed with difficulty breathing, and he received 125 mg of Solu-Medrol in the field.  The patient was kept on Solu-Medrol and agreed for remdesivir therapy.  He also received supportive care that included supplements and Singulair.
Vaccine injection 13:25, Two minutes later her client described sudden shooting sharp pain in the left neck and shoulder muscles. Pain rated 9/10, constant.  Client was given medical cold pack to apply, brought to a quiet area & sat at a table, drank cold water, encouraged to relax.   At 13:40, Additionally had intermittent cough and throat clearing but no respiratory symptoms. Speech was normal throughout episode, which presented more like esophageal spasm.  Talked with a nurse about 1 hr, Throat clearing and cough only lasted 20 minutes.  By 2:30 pm Pain diminished to achy muscle cramp in trapezius muscle and neck, VS WNL.  Client released, departed at 2:40 pm.
Became itchy at vaccine site & developed x 2 hours. On (R) arm.
HYPOTENSION  11/17/2022 - RECURRENCE OF SAME SYMPTOMS
really sick; sore throat; tested positive for COVID; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 08Feb2021 as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.1 week after vaccination, on an unknown date in Feb2021, the patient tested positive for COVID (sars-cov-2 test positive) and had to be in isolation for 10 days, the patient had been out of isolation for a couple of days now, maybe since Thursday or Friday. The patient had been out of school. However, on 01Mar2021 the patient woke up "really sick" with sore throat on the day of her second dose appointment. The patient was supposed to get her second dose on the day of report. The patient was supposed to get the vaccine within the next hour, but she read she shouldn't get the vaccine if she is not feeling well. The caller wants to know should she delay it (second dose) for a week or what. The patient was calling to move the vaccine appointment one week instead of having it on the day of report. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on Feb2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report as received from a other health professional refers to an unknown number of patients of unknown age and gender. On an unknown date the patient was vaccinated with ROTATEQ (lot number and frequency unknown) (dosing regimen and frequency unkonwn) which under went temperature excursions outside recommended temperatures. No concomitant medications were reported. No adverse event was reported. No product quality issue was reported. This case is related to case numbers 1403USA009427, 1403USA009542 and 1403USA009543 via same reporter link. Additional information has been requested.
Information has been received from a physician concerning a 5 year old male who on 13-JAN-2002, was vaccinated with subcutaneous Varivax. On 23-FEB-2006, the patient experienced mild breakthrough varicella. Subsequently, the patient recovered from mild breakthrough varicella. Additional information has been requested.
This spontaneous report as received from a nurse practitioner refers to a patient of unknown age and gender. Medical history and drug reactions/allergies were not reported. On an unknown date, improperly stored dose of RECOMBIVAX HB (lot, dose and route not reported) might have been administered to a patient. Concomitant medication was not reported. No adverse effects reported. Additional information has been requested.
Customer developed a red rash that was hot to the touch. He also had a fever of 101.7 degrees. He decided to go to urgent care where customer states that he was diagnosed with a "skin infection" and was given a prescription for an antibiotic (doxycycline).
My daughter, 11yo, received HPV vaccine around 3:30pm.  At 9pm she reported feeling slight nausea.  At 2pm she woke me up reporting acute nausea, dizziness, terrible headache, muscle pain, pain in arms, legs and skin.  She had a fever of 101.   Around 3am she began vomiting , seeing double and saying her eyeballs hurt.  She was very weak and could hardly walk or sit up in bed. She dry heaved on/off for 2 hours. She reported her skin was so painful that it was intolerable for me to gently touch her back or shoulder.  Her symptoms began to improve in the morning.  She was weak, fatigued and nauseous the remainder of the day. By the following day her symptoms were 90% relieved.  Since this event, 4 weeks ago, she has frequently mentioned feeling unusually fatigued, dizzy,  headache, sore skin and pain in the eyes.  She has never had ongoing complaints like this.
Post 3rd dose of vax, the pt experienced severe arthritis. Treatment and outcome of the event was not specified. Please note that the event of arthritis does not meet ICH serious criteria but is being submitted expeditiously per FDA request.
arm became very sore and was unable to move or lift items with it the evening after the vaccine. the redness and swelling traveled from the vaccination site to the inner arm near elbow. as of 6/16/21 the puffiness was still visible. patient reports no discomfort.
pt recv vax SEP96 & pt devel breakthrough chickenpox which consisted of an unk number of lesions;the reporter stated that an additional pt (WAES # 97030697) exp a similar rxn to varicella;
Type 2 allergic reaction rash all over body. Bruising all over legs and thighs. treated with oral steriods and histamines
after receiving vaccine patient complain of dizzy, feeling flush and tinnitus. bradycardia 48 lasting 4-5 mins. BP 118/66.  patient monitored for 30 mins. prior to discharge patient states she feeling better , HR increase 62, bp 120/70
3 CCU RNs called in sick the following day after receiving their 2nd dose of the vaccine; This is a spontaneous report from a contactable other health care professional (hcp). This other hcp reported similar events for three patients. This is the third of three reports.   A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of BNT162B2 for COVID-19 immunization on an unknown date. The patient (a CCU RN (nurse)) called in sick the following day after receiving the 2nd dose of the vaccine on an unknown date. The outcome of the event sick was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021039437 Same reporter, same product, same event, different patients;US-PFIZER INC-2021039440 Same reporter, same product, same event, different patients.
Left arm is still sore from elbow to shoulder.; This is a spontaneous report from a contactable reporter (consumer or other non-HCP).  A 35-year-old female patient (not pregnant) received bnt162b2 (COVID-19 VACCINE - MANUFACTURER UNKNOWN), administered in left arm, administration date 27Aug2021 at 16:00 (Lot number: unknown) at the age of 35 years as dose 1, single for COVID-19 immunisation and the patient also received bnt162b2 (COVID-19 VACCINE - MANUFACTURER UNKNOWN), administration date on an unknown date in Sep2021 (Lot number: unknown) as dose 2, single for COVID-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medication. The following information was reported PAIN IN EXTREMITY (non-serious) with onset 30Sep2021, outcome not recovered. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain in extremity.  Second shot was end of September. Reported to my doctor as well. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the prior to the COVID-19 vaccine. Since the vaccination, the patient had been tested for COVID-19. The event resulted in doctor or other healthcare professional office/clinic visit.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Initially kind of hoarseness or a touch of laryngitis but I did not feel ill for a day and a half or so. Then I started to get headache, stuffiness in my nose, upper respiratory congestion, more than laryngitis, feverish but more so at night. I felt flu-like and like I had been hit by a truck. Very lethargic. A few days later I had almost nerve pain in my upper jaw that lasted on and off for two to three days and then went away. The pain was not severe but it was very strange but it did go away. I continued to have a mild cough. I do not have any problem breathing but I started to feel a wheeze. Spouse told her she wakes up in the middle of the night wheezing and coughing. My doctor prescribed an antihistamine. I didn't see a change so I did go see my doctor and he confirmed the wheezing. Doctor gave me an oral steroid which helped a little but now I'm back where I was before. I am now using an inhaler daily, BREO ELLIPTA. I didn't have any wheezing or coughing prior to contracting COVID-19.
1/17/07 3pm patient reports body pain, abdominal pain, vomiting, dizziness, fever, diarrhea. They went to emergency room because they thought it maybe an adverse reaction to the Yellow Fever vaccination. ER did pregnancy test which came back positive.  03/26/2007 MR received from ER visit of 01/18/07 for c/o abdominal pain, diarrhea,  and vomiting x 2 weeks with (+) home pregnancy test.  LMP 12/15/2006.  PE: WNL. Discharged to OB MD for aspiration in office. Discharge Diagnosis:  Vomiting, Pregnancy, R/O Ectopic.
Two days after caught the only cold; Initial information was received on 02-Nov-2021 regarding an unsolicited valid non-serious case received from social media from consumer/non-health care professional via Medical information (under reference number - US-SA-SAC20211109000972).  This case involves adult patient of unknown age and gender who experienced two days after caught the only cold (nasopharyngitis), after receiving vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), concomitant therapy, concomitant medication(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious two days after caught the only cold (nasopharyngitis) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported "I've had in 20 years. Other guys I know said the same happened to them. I don't do vaccines anymore.  It is unknown if the patient experienced any additional symptoms/events.  No additional laboratory data was reported.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was unknown for the event.  There will be no information available on batch number for this case.